...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Estimated Glomerular Filtration Rate

" I am still expecting to see kidney function deteriorate in the placebo group and improve in the apabetalone/RVX-208 group."

Should RVX-208 improve eGRF, would this synergy be part and parcel of the existing RVX-208 patent, or would it need to be covered by a new patent?  

Koo

 

 

 

 

 

 

 

Share
New Message
Please login to post a reply